Author:
Brown J E,Thomson C S,Ellis S P,Gutcher S A,Purohit O P,Coleman R E
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Ali SM, Demers LM, Leitzel K (2000) Elevated serum N-telopeptide predicts poor prognosis in breast cancer patients with bone metastases. Proc Am Soc Clin Oncol 19, Abstract 2549
2. Armitage P, Berry G (1994) Statistical Methods in Medical Research, 3rd ed, Oxford: Blackwell Scientific Publications
3. Berenson JR, Rosen LS, Howell A, Porter L, Coleman RE, Morley W, Dreicer R, Kuross SA, Lipton A, Seaman JJ (2001) Zoledronic acid reduces skeletal events in patients with osteolytic metastases. Cancer 91: 1191–1200
4. Coleman RE, Rubens D (1987) The clinical course of bone metastases from breast cancer. Br J Cancer 55: 61–66
5. Gonnelli R, Cepollara C, Pondrelli C (1997) The usefulness of bone turnover in predicting the response to transdermal estrogen therapy in postmenopausal osteoporosis. J Bone Min Res 12: 624–631
Cited by
145 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献